{"version":"1.0","type":"link","title":"Real-world efficacy and safety of transarterial chemoembolization plus sintilimab and bevacizumab biosimilar for intermediate-advanced hepatocellular carcinoma: a propensity score matching study.","author_name":"Deng LW 외","author_url":"https://prs-insight.online/author/Deng%20LW","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/106310","thumbnail_width":1200,"thumbnail_height":630}